DNA methylation and transcriptional profiles of IRF5 gene in ankylosing spondylitis: A case-control study.

[1]  Shiyang Guan,et al.  Ankylosing Spondylitis Patients Display Aberrant ERAP1 Gene DNA Methylation and Expression , 2021, Immunological investigations.

[2]  Ronita Nag Chaudhuri,et al.  DNA methylation and regulation of gene expression: Guardian of our health , 2021, The Nucleus.

[3]  T. Taniguchi,et al.  Genetic and chemical inhibition of IRF5 suppresses pre-existing mouse lupus-like disease , 2021, Nature Communications.

[4]  M. Brown,et al.  Ankylosing spondylitis: an autoimmune or autoinflammatory disease? , 2021, Nature Reviews Rheumatology.

[5]  Shanshan Xu,et al.  Association of methylation level and transcript level in TRAF5 gene with ankylosing spondylitis: a case-control study , 2021, Genes & Immunity.

[6]  Jinfang Zhu,et al.  Recent advances in understanding the Th1/Th2 effector choice , 2021, Faculty reviews.

[7]  Yuhua Su,et al.  Aberrant Methylation of miR-34b and IL-12B mRNA Promoters Contributes to the Reduced Severity of Ankylosing Spondylitis , 2021, Biochemical Genetics.

[8]  M. Brown,et al.  Inflammasome Activation in Ankylosing Spondylitis Is Associated With Gut Dysbiosis , 2021, Arthritis & rheumatology.

[9]  Jing-Yang Huang,et al.  The association between Candida infection and ankylosing spondylitis: a population-based matched cohort study , 2020, Current medical research and opinion.

[10]  W. Tao,et al.  Multiomics and Machine Learning Accurately Predict Clinical Response to Adalimumab and Etanercept Therapy in Patients With Rheumatoid Arthritis , 2020, Arthritis & rheumatology.

[11]  Shan Sun,et al.  Inhibition of IRF5 hyper-activation protects from lupus onset and severity. , 2020, The Journal of clinical investigation.

[12]  H. Xiong,et al.  IRF5 Acts as a Potential Therapeutic Marker in Inflammatory Bowel Diseases. , 2020, Inflammatory bowel diseases.

[13]  C. Abraham,et al.  T Cell-Intrinsic IRF5 Regulates T Cell Signaling, Migration, and Differentiation and Promotes Intestinal Inflammation. , 2020, Cell reports.

[14]  B. Barnes,et al.  Potential T Cell-Intrinsic Regulatory Roles for IRF5 via Cytokine Modulation in T Helper Subset Differentiation and Function , 2020, Frontiers in Immunology.

[15]  S. Lai,et al.  Incidence of inflammatory bowel disease in patients with ankylosing spondylitis , 2019, Annals of the Rheumatic Diseases.

[16]  X. Weng,et al.  Ankylosing spondylitis: etiology, pathogenesis, and treatments , 2019, Bone Research.

[17]  A. Reimold,et al.  Genome-wide DNA methylation analysis in ankylosing spondylitis identifies HLA-B*27 dependent and independent DNA methylation changes in whole blood. , 2019, Journal of autoimmunity.

[18]  D. Darmochwal-Kolarz,et al.  IRF5 promoter methylation as a new potential marker of rheumatoid arthritis. , 2019, Polish archives of internal medicine.

[19]  Jian-hua Xu,et al.  Ankylosing spondylitis is associated with aberrant DNA methylation of IFN regulatory factor 8 gene promoter region , 2019, Clinical Rheumatology.

[20]  I. Udalova,et al.  Advances and challenges in targeting IRF5, a key regulator of inflammation , 2018, The FEBS journal.

[21]  L. Altan,et al.  Effect of cigarette smoking on sexual functions, psychological factors, and disease activity in male patients with ankylosing spondylitis , 2018, The aging male : the official journal of the International Society for the Study of the Aging Male.

[22]  Ashwinder Kaur,et al.  IRF5-mediated immune responses and its implications in immunological disorders , 2018, International reviews of immunology.

[23]  D. Gladman,et al.  Axial disease in psoriatic arthritis and ankylosing spondylitis: a critical comparison , 2018, Nature Reviews Rheumatology.

[24]  A. Syvänen,et al.  DNA methylation mapping identifies gene regulatory effects in patients with systemic lupus erythematosus , 2018, Annals of the rheumatic diseases.

[25]  A. Orekhov,et al.  The impact of interferon-regulatory factors to macrophage differentiation and polarization into M1 and M2. , 2018, Immunobiology.

[26]  L. Kovács,et al.  The Impact of Anti-TNF Therapy on CD4+ and CD8+ Cell Subsets in Ankylosing Spondylitis , 2017, Pathobiology.

[27]  Xiong Guo,et al.  Genome-wide DNA methylation profile analysis identifies differentially methylated loci associated with ankylosis spondylitis , 2017, Arthritis Research & Therapy.

[28]  S. Wenzel,et al.  IRF5 distinguishes severe asthma in humans and drives Th1 phenotype and airway hyperreactivity in mice. , 2017, JCI insight.

[29]  M. Garshasbi,et al.  Evaluation of DNMT1 gene expression profile and methylation of its promoter region in patients with ankylosing spondylitis , 2016, Clinical Rheumatology.

[30]  I. Udalova,et al.  Interferon regulatory factor 5 in human autoimmunity and murine models of autoimmune disease. , 2016, Translational research : the journal of laboratory and clinical medicine.

[31]  M. Feldmann,et al.  IRF5 controls both acute and chronic inflammation , 2015, Proceedings of the National Academy of Sciences.

[32]  I. Udalova,et al.  Activation and function of interferon regulatory factor 5. , 2015, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[33]  L. Bradbury,et al.  Genetic Dissection of Acute Anterior Uveitis Reveals Similarities and Differences in Associations Observed With Ankylosing Spondylitis , 2015, Arthritis & rheumatology.

[34]  R. Gay,et al.  Epigenome Analysis Reveals TBX5 as a Novel Transcription Factor Involved in the Activation of Rheumatoid Arthritis Synovial Fibroblasts , 2014, The Journal of Immunology.

[35]  Ming-Chi Lu,et al.  Association between cytokines and methylation of SOCS-1 in serum of patients with ankylosing spondylitis , 2014, Molecular Biology Reports.

[36]  M. Dougados,et al.  How to deal with missing items in BASDAI and BASFI. , 2014, Rheumatology.

[37]  Judith A. Smith.  Update on Ankylosing Spondylitis: Current Concepts in Pathogenesis , 2014, Current Allergy and Asthma Reports.

[38]  Youngkyun Lee.  The role of interleukin-17 in bone metabolism and inflammatory skeletal diseases , 2013, BMB reports.

[39]  Lisong Yang,et al.  Irf5‐deficient mice are protected from pristane‐induced lupus via increased Th2 cytokines and altered IgG class switching , 2012, European journal of immunology.

[40]  H. J. Kim,et al.  IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodeling , 2009, Cell Death and Differentiation.

[41]  J. Braun,et al.  Ankylosing spondylitis , 2007, The Lancet.